Small biopharma companies often need to partner with larger firms to achieve their goals. Here, Diane Seimetz and Jörg Schneider discuss how due diligence smooths the path to collaboration.

Watch our on-demand webinar with Altasciences to learn the key advantages and differences of conducting early phase clinical trials in North America versus other geographic regions.

US Government investigation report suggests Emergent Biosolutions destroyed almost 400 million doses of COVID-19 vaccine and worked to conceal quality issues from the FDA.

AstraZeneca has entered into a licence agreement with RQ Biotechnology Ltd for a portfolio of early-stage monoclonal antibodies (mAbs) targeted against SARS-CoV-2.

The East Syracuse site will serve as the LOTTE Centre for North America Operations for LOTTE’s new biologics contract development and manufacturing organisation (CDMO) business in the United States.